Login / Signup

First in human randomised trial of J2H-1702: A novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor for non-alcoholic steatohepatitis treatment.

Yun KimShi-Ra LeeSang Won Lee
Published in: Alimentary pharmacology & therapeutics (2023)
The results of this study suggest that J2H-1702 could be developed as an effective therapeutic option for NASH.
Keyphrases
  • endothelial cells
  • study protocol
  • induced pluripotent stem cells
  • randomized controlled trial
  • clinical trial
  • pluripotent stem cells
  • combination therapy
  • smoking cessation